Video

Dr. Gralow on the Integration on Precision Medicine Into Oncology

Julie R. Gralow, MD, discusses the integration of precision medicine into oncology.

Julie R. Gralow, MD, clinical director, Breast Medical Oncology, Seattle Cancer Care Alliance, professor, medical oncology, University of Washington School of Medicine, discusses the integration of precision medicine into oncology.

Historically, cancer treatment consisted of a one-size-fits-all approach, says Gralow. Now, with molecular profiling, therapies are being tailored to individual subgroups of patients with cancer based on acquired disease characteristics. Moreover, serial biopsies with plasma-based testing are needed to identify changes in molecular characteristics that can occur as rapidly as between recurrences, Gralow explains. Notably, these changes can affect disease aggressiveness and response to treatment.

Additionally, germline characteristics, age, comorbidities, and patient goals have extended the reach of personalized therapy, Gralow concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
The Role of the Multidisciplinary Care Team in the Diagnosis and Management of Acute Hepatic Porphyria
Video

The Role of the Multidisciplinary Care Team in the Diagnosis and Management of Acute Hepatic Porphyria

Apr 28th 2025 - Apr 29th 2026

online-activity
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Apr 28th 2025 - Apr 29th 2026

online-activity
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 24th 2025 - Apr 25th 2026

online-activity